UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
CLYM holding history
Climb Bio, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLYM overviewAll 13F holders of CLYMFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,404,866
- Value
- $44.4M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,404,866 | $44.4M | <0.1% | +3,318,921+3,861.7% | Added | Holders |
| Q1 2026 | 85,945 | $588.7K | <0.1% | +14,622+20.5% | Added | Holders |
| Q4 2025 | 71,323 | $285.3K | <0.1% | −334,081−82.4% | Reduced | Holders |
| Q3 2025 | 405,404 | $814.9K | <0.1% | +22,922+6.0% | Added | Holders |
| Q2 2025 | 382,482 | $474.3K | <0.1% | +257+0.1% | Added | Holders |
| Q1 2025 | 382,225 | $466.3K | <0.1% | −33,130−8.0% | Reduced | Holders |
| Q4 2024 | 415,355 | $747.6K | <0.1% | +399,108+2,456.5% | Added | Holders |
| Q3 2024 | 16,247 | $82.7K | <0.1% | +14,029+632.5% | Added | Holders |
| Q2 2024 | 2,218 | $15.8K | <0.1% | −3,707−62.6% | Reduced | Holders |
| Q1 2024 | 5,925 | $16.2K | <0.1% | +5,925 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −89−100.0% | Sold out | Holders |
| Q3 2023 | 89 | $234 | <0.1% | +89 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −2,282−100.0% | Sold out | Holders |
| Q2 2022 | 2,282 | $7.00K | <0.1% | +666+41.2% | Added | Holders |
| Q1 2022 | 1,616 | $14.0K | <0.1% | −2,822−63.6% | Reduced | Holders |
| Q4 2021 | 4,438 | $47.0K | <0.1% | −9,435−68.0% | Reduced | Holders |
| Q3 2021 | 13,873 | $249.0K | <0.1% | +13,873 | New | Holders |